(UroToday.com) In the Indian Urology Symposium held in conjunction with this year’s virtual Société Internationale d’Urologie (SIU) annual congress, Dr. Anant Kumar examined the question of biomarkers for prostate cancer, specifically whether there are any new “game changers” beyond serum prostate-specific antigen (PSA).